Vital Therapies Receives $16,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=388fd699-a868-4e94-9a7a-0f201f172406&Preview=1 - Date
9/28/2012 - Company Name
Vital Therapies - Mailing Address
15222 Avenue of Science San Diego, CA 92128 - Company Description
Vital Therapies, Inc. (VTI) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix. - Website
http://www.vitaltherapies.com - Transaction Type
Venture Equity - Transaction Amount
$16,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The San Diego-based company plans to use the capital to run Phase III clinical trials of a product that combines liver cells with a medical device that could help people with acute liver failure. - M&A Terms
- Venture Investor
Undisclosed
